Blockchain and AI are opening new pathways for development of longevity science. Working in tandem, they have the chance to use biomedical data for AI algorithms to be successful.
The important thing is that the blockchain is sharing patients’ data with their consent and them being aware of their personal information from medical records being used. The company Longenesis has deployed a solution in state hospitals, government biobanks and elsewhere.
Its work empowers AI companies such as Insilico Medicine to access vast amounts of data that can be used for artificial intelligence analysis, leading to even more treatment and drug discovery.
Read more cointelegraph.com